Journal
Nature Communications
Publication Date
2020
Volume
11
Issue
1
First Page
6262
Document Type
Open Access Publication
DOI
10.1038/s41467-020-19810-w
Rights and Permissions
Ribas, A., Algazi, A., Ascierto, P. A., Butler, M. O., Chandra, S., Gordon, M., . . . Robert, C. (2020). PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma. Nature Communications, 11(1) doi:10.1038/s41467-020-19810-w Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Recommended Citation
Ribas, Antoni; Algazi, Alain; Ascierto, Paolo A.; Butler, Marcus O.; Chandra, Sunandana; Gordon, Michael; Hernandez-Aya, Leonel; Lawrence, Donald; Lutzky, Jose; Miller, Wilson H. Jr.; Campbell, Katie M.; Delafont, Bruno; Marshall, Shannon; Mueller, Nancy; and Robert, Caroline, "PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma." Nature Communications. 11, 1. 6262 (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9972
41467_2020_19810_MOESM1_ESM.pdf (768 kB)
AUTHOR~1.PDF (377 kB)
